Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD)
Type II Diabetes Mellitus
Enrolment: 100 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Type II Diabetes Mellitus
Enrolment: 100 · Results not recorded
Echolocation
Enrolment: 12 · Results not recorded
Intracanal Medicaments · Inflammatory Cytokines
Enrolment: 36 · Results not recorded
Healthy Subjects · Bioavailability
Enrolment: 22 · Results not recorded
Insulin Resistance · Metabolic Syndrome
Enrolment: 22 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute lung injury induced by intratracheal peroxynitrite injection, assessed at 24 and 48 h
Peroxynitrite raised inflammatory mediators and tissue injury scores relative to control. Oleanolic acid treatment significantly reduced these markers and tissue injury scores, with p<0.001 for TNF-alpha and apoptosis at 48 h.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.